The Ozempic and Wegovy mistake sending thousands to poison control

The surge in poison control calls related to semaglutide, used in both Ozempic and Wegovy, highlights a growing issue of accidental overdoses following its approval for weight management. Experts attribute the rise to confusion over dosing instructions, rather than intentional misuse. With proper education on the correct weekly dosage and gradual dose increases, many of these avoidable incidents could be prevented, underscoring the importance of clear patient information to ensure safe medication use. This situation emphasizes the need for better patient guidance to avoid adverse outcomes from widely prescribed drugs.